chapter
look
use
microlithograph
fabric
biochip
platform
dna
diagnost
prognost
although
protein
rna
biochip
also
briefli
consid
biodetect
method
ionselect
electrod
ise
microelectromechan
system
mem
devic
microcantilev
optic
piezoelectricbas
acoust
wave
mass
spectrometri
briefli
discuss
emphasi
given
labelfre
electrochem
impedimetr
voltammetr
amperometr
detect
product
dna
biochip
highlight
oper
design
experi
reveal
gene
express
snp
data
applic
discuss
includ
monitor
microb
cancer
classif
studi
patient
stratif
drug
develop
final
challeng
issu
face
develop
diagnost
prognost
biochip
discuss
detail
biochip
contract
impli
incorpor
biolog
deriv
recognit
entiti
addit
subtract
techniqu
microlithographi
product
use
analyt
devic
biochip
similar
may
distinguish
biosensor
densiti
function
recognit
site
gener
biochip
highli
versatil
devic
may
use
clinic
diagnost
prognost
patient
stratif
drug
develop
diseas
manag
forens
applic
amongst
other
biochip
autom
repetit
laboratori
task
replac
standard
equip
miniatur
microfluid
assay
therebi
provid
sensit
detect
method
recent
time
three
main
type
biochip
becom
import
diagnost
prognost
purpos
nucleic
acid
dna
rna
pnabas
type
protein
biochip
dna
biochip
may
classifi
accord
two
type
nucleic
acid
probe
affix
chip
surfac
densiti
probe
present
sampl
probe
may
cdna
gener
deriv
bacteri
clone
librari
oligonucleotid
prepar
solidphas
synthesi
oligonucleotid
may
situ
synthes
presynthes
affix
chip
substrat
one
format
dna
biochip
use
piec
glass
typic
size
microscop
slide
contain
thousand
cdna
probe
affix
glass
platform
within
tini
ca
polyacrylamid
gel
pad
magichip
microarray
gelimmobil
compound
chip
fulli
integr
sampl
prepar
microfluid
sampl
manag
analyt
detect
system
commonli
term
labonachip
may
allow
fieldport
dna
analys
dna
biochip
wide
use
detect
mutat
specif
gene
detect
differ
gene
express
level
cell
rnabas
biochip
first
report
breaker
group
yale
use
rnabas
molecular
switch
goldcoat
silicon
surfac
arrang
cluster
switch
abl
bind
one
specif
target
molecul
research
abl
identifi
differ
strain
e
coli
protein
biochip
increasingli
develop
sever
format
avail
includ
antibodi
array
detect
antigen
bodi
fluid
ii
tissu
extract
purifi
antigen
array
detect
serum
antibodi
known
protein
iii
bait
protein
immobil
detect
interact
protein
iv
largescal
proteom
array
entir
express
librari
encod
fusion
protein
gener
protein
biochip
similar
dna
microarray
instead
compos
array
immobil
protein
surfac
prepar
immobil
method
far
complex
intric
order
mitig
surfacemedi
denatur
provid
preferenti
orient
activ
site
complement
bind
domain
analyt
solut
addit
dnarna
protein
subcellular
organel
cell
tissu
may
also
basi
biorecognit
biochip
chapter
howev
concentr
biochip
platform
dna
diagnost
consid
topic
includ
biorecognit
moieti
biodetect
method
microarray
opportun
biochip
diagnost
prognost
use
patient
stratif
drug
develop
chapter
conclud
discuss
key
issu
relat
product
use
diagnost
prognost
biochip
sever
biomolecul
use
recognit
moieti
develop
dna
biochip
includ
cdna
oligomer
dna
pna
well
rna
integr
solidst
devic
biomolecular
recognit
entiti
need
immobil
stabil
present
target
maxim
hybrid
kinet
hybrid
fidel
well
maxim
subjac
devic
sensit
five
main
class
gener
immobil
techniqu
major
advantag
irrevers
immobil
may
allow
reus
devic
system
b
immobil
molecul
may
stabl
solut
speci
regardless
approach
taken
goal
har
specif
recognit
properti
biomolecul
done
either
discret
part
complex
system
recognit
reaction
link
physicochem
transduct
devic
made
function
integr
analyt
system
wide
rang
possibl
detect
method
give
biochip
divers
includ
electron
devic
field
effect
transistor
microelectromechan
mem
devic
micro
nanocantilev
simpl
metal
semiconductor
electrod
electrochem
amperometr
voltammetr
impedimetr
detect
optic
devic
includ
fiber
fiber
bundl
absorpt
fluoresc
luminesc
chemiluminesc
quartzcryst
oscil
devic
mass
spectrometri
amongst
method
describ
direct
other
indirect
direct
method
deriv
signal
hybrid
reaction
directli
exampl
quartz
crystal
oscil
impedimetr
biochip
microand
nanocantilev
interferomet
detect
method
exemplifi
respons
requir
label
therefor
also
refer
labelfre
method
although
labelfre
signal
may
enhanc
limit
detect
lower
sensit
increas
dynam
rang
attenu
use
nanoparticl
chemic
respons
label
indirect
method
deriv
signal
measur
label
exampl
radioact
isotop
fluoresc
label
method
briefli
describ
succeed
paragraph
ionselect
electrod
ise
allow
greater
specif
achiev
especi
singleus
applic
improv
semiconductor
technolog
led
develop
fieldeffect
transistor
fet
usurp
ise
platform
fet
high
imped
transistor
sensit
measur
small
potenti
requir
low
current
made
use
technolog
howev
fet
prove
expens
produc
yet
achiev
full
commerci
potenti
small
part
difficulti
regard
reliabl
oper
develop
commerci
phfet
emerg
organ
thin
film
field
effect
transistor
tft
suggest
dna
fet
may
becom
technolog
commerci
possibl
mem
devic
prove
popular
modern
method
detect
biomolecul
may
combin
mechan
part
sever
unit
oper
sensor
actuat
electron
common
silicon
substrat
util
microfabr
technolog
technolog
allow
integr
siliconbas
microelectron
micromachin
approach
sophist
detect
system
allow
develop
complet
systemsonachip
enabl
technolog
allow
mem
includ
polymeras
chain
reaction
pcr
microsystem
dna
amplif
identif
biochip
detect
chemic
biolog
agent
microsystem
highthroughput
drug
screen
select
electrochem
method
gener
accur
sensit
instrument
techniqu
one
wide
use
method
voltammetri
make
use
microelectrod
platinum
wire
potenti
electrod
vari
gener
linear
sweep
result
current
record
function
appli
potenti
microelectrod
restrict
current
nanoamper
result
concentr
test
substanc
solut
remain
essenti
unchang
experi
amperometri
applic
voltammetr
measur
fix
potenti
detect
chang
current
function
chemic
potenti
electroact
speci
amperometr
electrod
made
microscal
diamet
allow
enhanc
mass
transport
independ
flow
increas
signaltonois
ratio
measur
highresist
media
describ
later
electrochem
method
allow
miniatur
instrument
use
dna
hybrid
one
reason
rapid
progress
biochip
field
advanc
optic
arena
evanesc
wave
phenomenon
one
exampl
light
reflect
optic
interfac
chang
refract
index
decay
energi
away
point
reflect
surround
medium
evanesc
wave
use
excit
fluoresc
molecul
bound
surfac
waveguid
phenomenon
term
total
intern
reflect
fluoresc
tirf
howev
excit
electron
plasma
thin
metal
layer
cover
surfac
waveguid
process
call
surfac
plasmon
reson
spr
phenomena
consider
surfac
sensit
receiv
consider
attent
develop
dna
biochip
anoth
major
develop
introduct
optic
fiber
optic
fiber
bundl
optic
fiber
outer
black
polymer
sheath
provid
protect
avoid
coupl
ambient
light
wall
give
mechan
support
strain
relief
inner
core
fiber
optic
detect
circuitri
complet
electr
isol
point
measur
import
safeti
implic
clinic
diagnost
devic
fiber
optic
devic
possibl
use
small
polym
microspher
coat
absorb
fluoresc
dye
sphere
place
within
hollow
tube
fix
onto
end
fiber
bundl
attach
directli
surfac
fiber
optic
use
microspher
increas
surfac
area
avail
immobil
biorecognit
molecul
interact
sampl
applic
piezoelectricbas
acoust
wave
devic
dna
detect
also
import
develop
sensit
chang
mass
densiti
viscos
acoust
coupl
phenomena
therefor
seri
reson
frequenc
use
sensit
transduct
paramet
piezoelectr
crystal
devic
gener
transmit
acoust
wave
depend
frequenc
quartz
frequent
use
piezoelectr
crystal
act
masstofrequ
transduc
atcut
crystal
orient
plate
respect
crystal
plane
favor
excel
temperatur
coeffici
rang
one
first
sensor
introduc
piezoelectr
materi
thicknessshear
mode
tsm
sensor
substrat
quartz
may
commonli
term
quartz
crystal
microbal
qcm
bulk
acoust
wave
baw
sensor
mass
spectrometr
method
becom
import
includ
standard
approach
electrospray
ioniz
matrixassist
laser
desorpt
ioniz
maldi
recent
newer
techniqu
start
make
impact
includ
ion
mobil
spectrometri
im
abil
separ
ionic
speci
atmospher
pressur
research
current
underway
develop
lowpressur
im
system
b
atom
pressur
ioniz
api
proton
transfer
reaction
ptr
techniqu
rapid
sensit
specif
allow
measur
realtim
addit
suffer
drift
calibr
problem
key
featur
detect
modal
abil
produc
measur
respons
whether
directli
indirectli
nois
consequ
dna
hybrid
reaction
microarray
technolog
promis
dramat
speed
experiment
work
molecular
biologist
also
make
possibl
whole
new
experiment
approach
molecular
biolog
dna
microarray
exploit
order
twodimension
present
biorecognit
probe
entiti
fluoresc
tag
target
scan
confoc
imag
recognitiontarget
complex
hybrid
product
attract
featur
microarray
throughput
consequ
speed
analysi
potenti
miniatur
attend
reduct
sampl
volum
exist
still
fulli
realiz
allow
dna
microchip
technolog
great
potenti
rapid
multiplex
analysi
nucleic
acid
sampl
exampl
includ
diagnosi
genet
diseas
detect
infecti
agent
measur
differenti
gene
express
patient
stratif
drug
develop
drug
screen
forens
analysi
chip
often
fabric
glass
silicon
plastic
support
usual
compos
thousand
reaction
zone
diamet
onto
individu
cdna
andor
oligonucleotid
deposit
tether
result
densiti
sitescm
typic
cm
chip
highdens
dna
array
usual
requir
use
physic
deliveri
microjet
deposit
technolog
involv
dispens
picolit
volum
onto
discret
locat
chip
addit
contact
pin
array
spot
diamet
spot
microsolenoid
dispens
dispens
diamet
spot
also
wide
use
howev
highdens
dna
array
gener
benefit
activ
surfac
coval
attach
cdna
oligonucleotid
probe
success
develop
dna
chip
technolog
requir
multidisciplinari
approach
variou
technic
requir
satisfi
includ
develop
algorithm
informat
defin
oligonucleotid
probe
sequenc
length
method
fabric
probe
array
detect
target
hybrid
algorithm
analyz
data
reconstruct
target
sequenc
may
discern
simpl
procedur
care
experiment
work
necess
advent
autom
gene
chip
system
decreas
time
requir
analysi
reduct
human
error
gener
term
microarray
gene
express
analysi
work
exploit
abil
given
mrna
molecul
revers
transcrib
result
cdna
rt
product
success
hybrid
high
fidel
complementari
strand
dna
templat
origin
microarray
contain
mani
dna
probe
typic
possibl
determin
express
level
thousand
gene
within
cell
perform
singl
experi
measur
amount
cdna
bound
site
array
achiev
meaning
result
microarray
necessari
invest
proper
design
experi
usual
follow
step
involv
fluoresc
tag
excit
laser
use
confoc
microscop
camera
tandem
digit
imag
array
creat
date
microarray
technolog
larg
semiquantit
analyt
techniqu
valu
basic
research
arena
studi
use
microarray
serv
advanc
understand
diseas
process
technolog
evolv
becom
tool
clinic
medicin
provid
rich
sourc
inform
diseas
suscept
diagnosi
prognosi
research
tool
dna
microarray
alreadi
use
studi
heart
blood
vessel
lung
diseas
cystic
fibrosi
human
immunodefici
viru
cancer
singl
nucleotid
polymorph
use
broadli
well
studi
arabidopsi
rat
yeast
e
coli
genom
mous
model
addit
dna
microarray
increasingli
use
monitor
gene
express
human
research
use
rna
express
biochip
identifi
differenti
gene
express
relev
differ
biolog
state
clontech
palo
alto
ca
produc
atla
microarray
provid
sensit
detect
gene
express
use
fluoresc
dye
glass
nylon
substrat
evolut
microarray
use
inform
glean
genom
microarray
develop
pathwayspecif
diagnosticprognost
microarray
employ
smaller
suit
gene
highli
focus
assess
evolut
toward
socal
theme
array
begun
superarray
bioscienc
corpor
develop
human
gene
array
contain
gene
relev
understand
helper
cell
biolog
gene
includ
cytokin
specif
express
subtyp
array
also
contain
gene
encod
transcript
factor
regul
express
cytokin
well
marker
lymphocyt
simpl
sidebysid
hybrid
allow
rel
express
gene
experiment
rna
relat
product
includ
cancer
drug
resist
metabol
common
cytokin
inflammatori
cytokin
receptor
chemokin
receptor
interleukin
receptor
intelligen
dna
microarray
mediumdens
cdna
array
standard
cm
cm
glass
slide
standard
dual
color
analysi
use
highresolut
fluoresc
detect
array
target
human
cancer
human
cytokin
endocrin
disrupt
well
cyanobacteri
orf
arabidopsi
mous
e
coli
gene
analysi
movement
toward
confoc
imag
target
microarray
converg
dna
biochip
use
detect
technolog
confoc
fluoresc
imag
one
area
use
dna
microarray
prove
immens
import
monitor
microb
serv
detect
identif
tool
clinic
applic
commerci
avail
biochip
includ
helicobact
pylori
array
mwg
biotech
mycobacterium
tuberculosi
plasmodium
falciparum
candida
albican
chip
operon
e
coli
array
pan
vera
e
coli
pseudomona
aeruginosa
sever
acut
respiratori
syndrom
sar
biochip
affymetrix
e
coli
tuberculosi
array
sigmagenosi
compani
siebersdorf
research
germani
agil
creat
custommad
chip
organ
interest
relat
area
nanogen
inc
san
diego
ca
develop
electron
control
sampl
prepar
process
dielectrophoret
separ
e
coli
blood
cell
bacteria
lyse
highvoltag
puls
compani
fabric
sever
microelectron
chip
includ
contain
address
test
site
latter
develop
drug
discoveri
methodolog
major
academ
develop
research
st
georg
hospit
medic
school
london
form
group
call
bacteri
microarray
group
st
georg
fund
wellcom
trust
bring
bacteri
genom
research
around
world
organ
develop
wholegenom
array
pathogen
includ
campylobact
jejuni
haemophilu
influenza
yersinia
pesti
salmonella
typhi
collabor
effort
expect
immens
benefit
collect
research
gener
result
faster
basi
use
lead
effici
identif
procedur
posit
impact
health
care
system
bekal
cowork
describ
method
rapid
identif
e
coli
pathotyp
virul
gene
detect
e
coli
virul
factor
dna
microarray
compos
dna
pcr
amplicon
print
glass
slide
arrang
eight
subarray
correspond
differ
e
coli
pathotyp
develop
fluoresc
label
genom
dna
sequenc
hybrid
virul
gene
microarray
optim
valid
report
type
microarray
power
tool
gene
quantit
subtyp
final
listeria
speci
also
identifi
microarraybas
assay
six
speci
listeria
amplifi
multiplex
pcr
subsequ
hybrid
individu
oligonucleotid
probe
specif
listeria
speci
demonstr
method
allow
unambigu
detect
six
speci
base
sequenc
differ
iap
gene
author
conclud
microarray
valuabl
identif
character
bacteri
pathogen
must
born
mind
howev
huge
amount
data
gener
microarray
requir
expert
interpret
result
dna
microarray
also
use
identif
virus
although
area
still
infanc
recent
applic
includ
detect
human
immunodefici
viru
hiv
respons
aid
influenza
viru
former
two
method
nucleotid
sequenc
compar
detect
drug
resist
mutat
hiv
type
revers
transcriptas
rt
virus
isol
highli
rt
inhibitorexperienc
individu
found
amino
acid
deduc
popul
pcr
product
cycl
sequenc
sequenc
hybrid
highdens
array
oligonucleotid
probe
concord
method
discord
mainli
due
genet
mixtur
within
adjac
discord
codon
isol
evalu
addit
sequenc
molecular
clone
pcr
product
method
discord
method
less
frequent
latter
exampl
model
dna
microarray
shown
facilit
type
subtyp
human
influenza
b
virus
rtpcr
use
prepar
cdna
encod
bp
influenza
viru
gene
fragment
clone
sequenc
reamplifi
spot
onto
glass
support
target
dna
includ
multipl
fragment
hemagglutinin
neuraminidas
matrix
protein
gene
fluoresc
probe
hybrid
target
dna
array
scan
locat
probe
bind
site
research
indic
hybrid
pattern
agre
well
known
grid
locat
target
signaltobackground
ratio
vari
crosshybrid
could
detect
test
method
may
prove
clinic
use
differenti
amplifi
molecul
complex
mixtur
obtain
hybrid
combin
dna
particularli
attract
featur
research
identif
sever
set
multiplex
primer
collect
target
influenza
b
viru
strain
allow
dna
microarray
technolog
act
supplement
inform
obtain
pcrbase
diagnost
method
addit
research
center
biolog
evalu
research
nation
institut
allergi
infecti
diseas
develop
system
identifi
isol
rotavirus
organ
respons
caus
diarrhea
infant
develop
world
five
clinic
relev
g
genotyp
studi
genotypespecif
oligonucleotid
glass
slide
allow
bind
multipl
target
region
within
vp
gene
highli
conserv
among
individu
rotaviru
genotyp
nest
pcr
perform
identif
rotaviru
genotyp
base
hybrid
sever
individu
genotypespecif
oligonucleotid
advantag
microarray
approach
pcr
unambigu
identif
rotaviru
serotyp
approach
combin
high
sensit
pcr
select
dnadna
hybrid
furthermor
presenc
random
mutat
allow
individu
viru
isol
produc
uniqu
hybrid
pattern
allow
differenti
differ
isol
genotyp
de
risi
lab
report
approach
highli
parallel
viral
screen
long
mer
oligonucleotid
dna
microarray
capabl
simultan
detect
hundr
virus
develop
differ
virus
detect
use
viral
infect
cell
cultur
relat
viral
serotyp
distinguish
uniqu
hybrid
pattern
viru
offer
advantag
exist
techniqu
screen
broad
spectrum
virus
allow
comprehens
unbias
analysi
viral
preval
biolog
set
addit
individu
virus
explicitli
repres
microarray
detect
indic
method
may
find
use
viru
discoveri
import
aspect
research
abil
detect
multipl
virus
human
respiratori
specimen
without
use
sequencespecif
degener
primer
method
allow
discrimin
among
viral
subtyp
dna
array
also
found
use
cancer
classif
studi
differ
type
cancer
difficult
differenti
cancer
subtyp
exampl
cell
acut
myeloid
leukaemia
aml
acut
lymphoblastoid
leukaemia
look
similar
essenti
achiev
correct
diagnosi
treatment
regimen
may
differ
report
analyz
express
pattern
gene
array
repres
gene
accur
classif
possibl
aml
also
array
allow
robust
diagnosi
test
base
singl
protein
activ
one
enzym
anoth
applic
dna
microarray
use
discoveri
new
cancer
subtyp
exampl
analysi
reveal
two
previous
unrecogn
subtyp
nonhodgkin
lymphoma
gene
express
pattern
renal
cell
carcinoma
assess
complementari
dna
microarray
renal
cell
carcinoma
compris
sever
histolog
type
differ
clinic
behavior
thu
accur
patholog
character
essenti
author
describ
gene
express
profil
renal
tumor
determin
dna
microarray
contain
uniqu
cdna
repres
differ
unigen
cluster
includ
character
human
gene
differ
pattern
gene
express
among
differ
tumor
type
readili
observ
genom
classif
brain
tumor
brain
tumor
subtyp
also
pursu
center
bioelectron
biosensor
biochip
neuroanatomi
project
use
gene
spot
oligonucleotid
mer
microarray
express
profil
variou
tumor
type
defin
effort
involv
close
work
among
bioengin
pathologist
biostatistician
neurosurgeon
result
semiquantit
natur
today
microarray
like
diagnost
array
futur
must
brought
quantit
clinic
relev
format
also
diagnost
commun
need
accommod
decis
intervent
base
quantit
riskbas
assess
fashion
similar
environment
commun
achiev
goal
design
fabric
microarray
need
brought
quantit
framework
greater
attent
paid
welldefin
highli
reproduc
surfac
chemistri
dna
probe
attach
protocol
procedur
rigor
defin
hybrid
protocol
furthermor
present
biochip
reader
slow
expens
current
confoc
scan
method
address
signal
qualiti
issu
optic
howev
electr
signal
process
method
also
use
reduc
interfer
includ
crosstalk
cancel
multiplex
scheme
plextek
essex
uk
claim
improv
obtain
design
linear
detector
sensit
control
current
emphasi
statist
manipul
data
address
engin
limit
interoper
variabl
contribut
nois
poor
precis
poor
accuraci
need
address
improv
design
fabric
implement
protocol
dna
microarray
current
normal
techniqu
implement
softwar
microarray
assum
fluoresc
background
within
spot
essenti
found
throughout
microarray
slide
measur
fluoresc
surround
spot
assumpt
howev
valid
background
fluoresc
spotloc
inaccur
estim
background
fluoresc
spot
creat
sourc
error
especi
gene
low
transcript
copi
nonspecif
adsorpt
target
cdna
oligo
cdna
probe
spot
may
address
includ
arabidopsi
gene
human
microarray
subtract
intens
nonspecif
adsorb
signal
probe
signal
final
dna
detect
scheme
use
metal
nanoparticl
quantum
dot
label
rather
fluoresc
organ
dye
subject
photobleach
develop
base
physic
properti
metal
nanoparticl
larg
extinct
scatter
coeffici
catalyt
abil
surfac
electron
effici
brownian
motion
solut
properti
result
nanoparticl
overcom
limit
fluoresc
label
cost
eas
use
select
sensit
opportun
applic
dna
biochip
attract
area
human
health
specif
area
person
medicin
r
invest
market
sale
distribut
cost
given
today
model
develop
technolog
driven
compani
support
similar
opportun
environment
industri
biotechnolog
sector
human
health
sector
present
opportun
nearpati
bedsid
physician
offic
clinic
laboratori
molecular
diagnost
laboratori
hospit
short
term
diagnost
biochip
like
impact
area
drug
develop
clinic
molecular
diagnost
howev
clinic
molecular
diagnost
repres
loom
opportun
separ
regulatori
challeng
broader
societ
concern
primari
goal
drug
research
determin
small
sampl
possibl
mani
differ
molecul
pair
possibl
format
biolog
activ
complex
pharmaceut
compani
must
perform
biochem
assay
phase
drug
develop
cycl
initi
screen
librari
avail
compound
focus
evalu
promis
new
drug
candid
clinic
test
drug
readi
market
assay
pois
becom
import
industri
move
toward
deliveri
drug
target
specif
genet
profil
critic
element
process
comprehens
evalu
patient
respons
base
molecular
indic
unlik
popul
prospect
screen
stratifi
select
prior
join
studi
limit
market
size
may
even
social
objection
like
subpopul
identifi
studi
screen
retrospect
establish
logic
genet
basi
exclus
nonrespond
identif
overrespond
within
target
popul
limit
cost
associ
develop
less
disrupt
wellestablish
drug
develop
process
key
featur
procur
bank
tissu
andor
fluid
specimen
patient
particip
studi
diagnost
biochip
featur
promin
mean
provid
critic
molecular
data
drug
discoveri
improv
drug
discoveri
process
enabl
proper
patient
stratif
clinic
trial
one
import
develop
recent
time
use
singl
nucleotid
polymorph
snp
pronounc
snip
snp
common
type
variat
human
genom
aris
result
singl
base
differ
code
protein
individu
variat
occur
everi
base
pair
genom
make
major
three
million
variat
genom
furthermor
frequenc
particular
polymorph
remain
stabl
popul
usual
effect
singl
snp
gene
larg
small
effect
influenc
suscept
common
diseas
alzheim
risk
heart
diseas
oligonucleotid
dna
chip
use
discrimin
altern
base
site
snp
dna
chip
allow
mani
snp
arrang
parallel
necessari
largescal
associ
pharmacogenom
studi
dna
sequenc
contain
snp
hybrid
dna
chip
discrimin
altern
base
term
type
carri
polymorph
site
signal
correspond
specif
identifi
base
detect
two
type
method
wide
use
first
use
allelespecif
hybrid
short
dna
sequenc
chip
repres
possibl
variat
polymorph
site
label
dna
stick
exact
match
fluoresc
signal
indic
base
locat
secondli
oligonucleotid
chip
may
stop
one
base
variabl
site
type
depend
allelespecif
primer
extens
dna
sampl
attach
chip
use
templat
dna
synthesi
primer
immobil
nucleotid
four
nucleotid
ad
fluoresc
label
dna
polymeras
also
introduc
incorpor
base
identifi
fluoresc
signal
although
mass
spectrometri
may
also
use
method
suitabl
highthroughput
snp
type
usual
largescal
studi
popul
two
applic
associ
studi
tri
correl
snp
profil
suscept
diseas
b
pharmacogenom
studi
link
snp
profil
drug
respons
pattern
disadvantag
chipbas
assay
new
snp
readili
incorpor
onto
chip
howev
use
bead
array
problem
solv
snp
consortium
set
wellcom
trust
collabor
ten
big
pharmaceut
compani
sever
genom
research
institut
goal
produc
public
databas
snp
could
easili
access
fight
major
diseas
compani
contribut
us
million
endeavor
septemb
million
snp
five
time
origin
anticip
number
discov
recent
new
initi
establish
provid
haplotyp
map
genom
within
human
genom
differ
genet
variant
within
chromosom
region
haplotyp
found
possibl
combin
certain
combin
common
other
differ
haplotyp
may
associ
differ
suscept
diseas
map
haplotyp
structur
genom
genet
basi
diseas
may
identifi
fiven
consortium
canada
china
japan
unit
kingdom
unit
state
pledg
us
million
three
year
construct
haplotyp
map
base
genet
sampl
four
differ
popul
han
chines
yoruba
nigeria
japanes
individu
unit
state
northern
western
european
ancestri
hope
haplotyp
map
simplifi
search
medic
import
dna
sequenc
variat
provid
insight
human
popul
structur
histori
haplotyp
use
map
diseas
gene
possibl
mutat
respons
genet
diseas
alway
enter
popul
within
exist
haplotyp
ancestr
haplotyp
sever
gener
recombin
event
occur
within
haplotyp
diseas
allel
closest
snp
still
inherit
group
haplotyp
identifi
group
patient
diseas
type
allel
within
haplotyp
allow
conserv
region
identifi
mani
snp
present
gene
map
accur
intern
hapmap
project
aim
speed
discoveri
gene
relat
common
ill
asthma
cancer
diabet
heart
diseas
altern
genotyp
phenotyp
thu
antidepress
drug
fluoxetin
prozac
metabol
cytochrom
famili
enzym
produc
norfluoxetin
drug
metabolit
molecul
appear
urin
use
recombin
form
enzym
suitabl
design
biochip
allow
analysi
two
order
magnitud
variat
metabol
activ
found
popul
drug
compani
abtech
scientif
current
research
approach
although
measur
dna
directli
give
indic
clinic
manifest
variat
popul
core
technolog
base
interdigit
microelectrod
array
tini
electrod
deriv
metal
sputter
onto
substrat
microlithograph
fabric
chip
detect
biolog
relev
analyt
alreadi
produc
era
person
molecular
medicin
usher
univers
appreci
molecular
basi
diseas
molecular
analys
genet
proteom
improv
patient
outcom
manag
diseas
revolution
healthcar
potenti
optim
therapi
enabl
appropri
patient
dose
ii
detect
diseas
earli
stage
iii
greatli
reduc
advers
drug
reaction
drugdrug
interact
iv
potenti
improv
patient
complianc
clinic
molecular
diagnost
realiti
grow
signific
sever
clinic
molecular
diagnost
mdx
area
rapidli
emerg
mdx
optim
drug
dose
patient
select
patientspecif
dosag
univers
therapi
ii
mdx
select
patientspecif
therapi
applic
therapeut
drug
patient
presenc
absenc
particular
biomark
high
likelihood
favor
drug
respons
iii
mdx
molecular
grade
stage
diseas
particularli
cancer
develop
diagnost
prognost
test
accur
predict
patient
outcom
multistag
disord
mani
case
differenti
drug
respons
aris
subtl
differ
gene
code
product
drugmetabol
enzym
drug
transport
molecular
drug
target
receptor
particularli
noteworthi
amongst
drug
demonstr
differenti
drug
respons
drug
metabol
liver
enzym
cytochrom
larg
variat
cyp
activ
appar
popul
relat
principl
patient
stratif
drug
develop
develop
diagnost
test
measur
specif
protein
level
gene
copi
number
allow
emerg
drug
herceptin
gleevec
herceptin
antibodi
drug
specif
inhibit
cell
surfac
protein
human
epiderm
growth
factor
receptor
receptor
found
overexpress
approxim
breast
cancer
patient
histopatholog
defin
class
molecular
diagnost
test
exist
measur
protein
level
gene
copi
number
allow
identif
subset
patient
heceptin
indic
benefici
corollari
women
need
given
herceptin
first
cours
treatment
gleevec
tyrosin
kinas
inhibitor
specif
bind
atp
bind
site
inhibit
action
abnorm
form
bcrabl
protein
kinas
enzym
bcrabl
produc
kinas
respons
uncontrol
increas
white
blood
cell
popul
basi
chronic
myelogen
leukemia
cml
bcrabl
protein
fusion
two
normal
protein
result
chromosom
rearrang
molecular
diagnost
test
gene
code
bcrabl
allow
target
prescript
result
improv
respons
rate
lower
toxic
high
probabl
complet
remiss
mani
highli
regard
exampl
alreadi
avail
sever
yet
emerg
foretel
success
molecular
medicin
person
care
exampl
persuas
diagnost
test
link
avail
therapi
mdx
test
accompani
establish
therapi
may
sourc
frustrat
patient
provid
insur
alik
howev
test
period
ambival
may
well
basi
proper
patient
stratif
enabl
futur
develop
appropri
therapi
anoth
sourc
complic
aris
diseas
diseas
state
multigenet
challeng
first
arriv
suitabl
panel
gene
may
diagnost
prognost
diseas
outcom
second
challeng
implement
panel
gene
along
suitabl
analyt
control
onto
suitabl
geneosensor
biochip
platform
first
challeng
may
defin
part
challeng
class
comparison
identif
gene
differenti
express
among
predefin
class
diseas
first
challeng
may
also
defin
part
challeng
class
predict
identif
gene
differenti
express
among
patient
diseas
outcom
may
becom
known
case
technic
challeng
exacerb
like
emerg
genet
subclass
reveal
attempt
class
comparison
multipl
intervent
affect
patient
outcom
loom
question
whether
health
care
commun
prepar
accept
risk
base
determinist
paradigm
health
care
era
molecular
diagnost
person
medicin
one
import
nexu
futur
dna
microarray
found
clinic
diagnost
prognost
entail
develop
diagnost
tool
base
microarray
technolog
util
target
suit
gene
direct
specif
diagnost
screen
applic
center
bioelectron
biosensor
biochip
engag
develop
deploy
diagnost
prognost
biochip
primari
brain
tumor
biochip
seek
combin
focus
panel
gene
capabl
genet
delin
sever
world
health
organ
histopatholog
class
primari
brain
tumor
astrocytoma
microfluid
technolog
aim
support
sever
unit
oper
need
realiz
tissueindataout
bioanalyt
paradigm
two
parallel
effort
establish
conduct
retrospect
genet
class
comparison
class
delin
class
predict
studi
use
differenti
gene
express
profil
tissu
taken
tissu
data
bank
virginia
commonwealth
univers
develop
electroanalyt
techniqu
may
suit
rapid
hybrid
detect
transcript
clinic
molecular
diagnost
format
microarray
wide
appli
studi
differenti
gene
express
profil
improv
class
predict
mani
differ
cancer
type
includ
colon
lung
esophag
breast
cancer
variou
statist
method
develop
allow
improv
class
predict
use
microarray
data
parallel
consider
attent
given
render
microarray
data
quantit
rigor
optim
oligonucleotid
probe
length
definit
rel
end
ii
reproduc
coval
immobil
probe
qualifi
surfac
result
exact
surfac
coverag
iii
minim
nonspecif
adsorpt
target
refer
area
iv
implement
larger
number
control
featur
v
develop
advanc
reagent
set
allow
improv
detect
low
copi
number
transcript
stringent
hybrid
k
oligonucleotid
microarray
design
use
mwg
ka
human
oligonucleotid
librari
cat
mwg
base
gene
librari
seventeen
addit
housekeep
gene
eleven
control
gene
found
affymetrix
chip
tabl
ad
aminetermin
hplc
purifi
mer
oligonucleotid
mwg
set
addit
gene
serv
intern
control
allow
crossplatform
data
analysi
harmon
ongo
project
gene
librari
supplement
customdesign
mer
oligo
correspond
gene
previous
document
literatur
differenti
express
brain
tumor
mwg
librari
complet
list
gene
specif
probe
publicli
avail
oligo
librari
print
wt
anhydr
toluen
min
cure
min
borosil
glass
microscop
slide
use
cartesian
pixsi
microarray
array
produc
contact
print
pin
arrang
use
eight
parallel
synthesi
spot
pin
parallel
synthesi
santa
clara
ca
array
print
room
temperatur
air
atmospher
rel
humid
spot
buffer
ph
compos
mm
oligo
x
ssc
betain
diehl
total
independ
gene
spot
duplic
creat
array
total
featur
divid
subgrid
spot
fig
oligomicroarray
basi
crossplatform
perform
comparison
develop
crossplatform
correl
estim
intend
reveal
pattern
gene
express
enabl
retrospect
genet
class
comparison
class
delin
class
predict
use
differenti
gene
express
profil
irbapprov
bank
acquir
tissu
parallel
effort
develop
impedimetr
amperometr
dna
hybrid
detect
platform
consist
microlitho
graphic
fabric
interdigit
microsensor
electrod
microdisc
array
electrod
approach
focu
devis
mean
directli
detect
hybrid
dna
multiel
microelectrod
devic
serv
detector
fulli
integr
molecular
diagnost
system
consist
region
interdigit
microdisc
pad
compris
array
respect
fig
function
impedimetr
detect
nanoparticl
label
unlabel
dna
hybrid
wherea
allow
amperometr
detect
redoxlabel
dna
hybrid
reaction
fig
show
impedimetr
array
oppos
finger
micron
wide
mm
long
separ
micron
space
fig
show
voltammetr
amperometr
sensor
element
compris
hexagon
closepack
arrang
microdisc
form
microdisc
electrod
array
larg
area
time
area
microdisc
work
electrod
counter
electrod
refer
electrod
electrod
threeelectrod
electrochem
cellonachip
similarli
fabric
nm
magnetron
sputterdeposit
gold
egun
deposit
platinum
nm
titaniumtungsten
adhes
promot
layer
substrat
use
either
oxid
silicon
minimum
nm
thermal
grown
oxid
highli
polish
electronicsgrad
schott
borosil
glass
microdisc
array
work
electrod
compris
fluoroetch
open
mm
thick
silicon
nitrid
si
n
layer
deposit
onto
previous
pattern
nobl
metal
beneath
collect
biochip
allow
labelfre
impedimetr
detect
dna
hybrid
enhanc
impedimetr
detect
use
colloid
gold
nanoparticl
label
reversetranscrib
mrna
use
electroact
layer
poli
pyrrolecopyrrolyl
butan
provid
coval
attach
dna
probe
enhanc
redox
detect
sensit
electroact
label
ferrocen
signific
chang
electrochem
imped
valu
real
imaginari
compon
increas
imped
modulu
hz
detect
hybrid
coval
immobil
oligonucleotid
probe
complement
fig
show
impedimetr
sensor
element
compris
circumferenti
arrang
interdigit
microsensor
electrod
array
larg
area
time
area
interdigit
work
electrod
counterelectrod
refer
electrod
electrod
fourelectrod
electrochem
cellonachip
fabric
nm
magnetron
sputterdeposit
gold
egun
deposit
platinum
nm
titaniumtungsten
adhes
promot
layer
substrat
use
either
oxid
silicon
minimum
nm
thermal
grown
oxid
highli
polish
electronicsgrad
schott
borosil
glass
independ
address
interdigit
electrod
could
use
twoelectrod
electr
imped
combin
refer
electrod
threeelectrod
electrochem
imped
final
two
interdigit
electrod
could
short
use
singl
work
electrod
within
larg
area
counterelectrod
support
electrochem
oxid
reduct
appropri
electroact
speci
exampl
electroconduct
polym
grown
electropolymer
onto
region
interdigit
accomplish
format
final
refer
electrod
silversilv
chlorid
accompani
sensor
element
devic
prepar
silver
gold
platinum
layer
electrod
refer
electrod
provid
refer
potenti
electrochem
imped
amperometr
determin
multiplex
senor
element
array
fig
show
modifi
sensor
element
follow
silver
refer
electrod
bright
silver
prior
chloriod
shown
fig
show
modifi
sensor
element
follow
electropolymer
layer
exagger
polypyrrol
onto
region
interdigit
thin
film
polypyrrol
provid
anchorag
chemistri
coval
coupl
oligonucleotid
fig
show
voltammetr
amperometr
sensor
element
compris
hexagon
closepack
arrang
microdisc
form
microdisc
electrod
array
larg
area
time
area
microdisc
work
electrod
counterelectrod
refer
electrod
microdisc
independ
address
rather
exploit
ultramicroelectrod
electrochemistri
improv
sensit
dynam
rang
signaltonois
perform
singl
dna
probe
electrod
design
fig
may
also
implement
individu
sensor
element
microfluid
system
biochip
expect
greatest
impact
molecular
diagnost
market
major
challeng
go
well
beyond
usual
technolog
challeng
accept
clinic
detect
limit
level
sensit
specif
dynam
rang
repeat
reproduc
respons
time
immun
fals
posit
fals
neg
although
import
analyt
paramet
must
match
specif
assay
target
decis
context
acquir
data
one
addit
major
challeng
select
appropri
molecular
target
decidedli
link
diseas
suscept
drug
respons
prima
faci
point
initi
research
develop
activ
diagnost
biochip
second
major
challeng
overcom
fact
biochip
diagnost
simpli
addit
format
deliv
assay
could
otherwis
done
use
reagent
set
assay
approach
implement
chip
trivial
matter
overlook
identif
molecular
target
appropri
would
origin
use
labbas
assay
biochip
format
must
therefor
offer
signific
competit
advantag
labbas
equival
area
competit
advantag
diagnost
prognost
biochip
may
includ
th
follow
higher
throughput
biochip
format
autom
may
permit
handl
mani
sampl
reduc
overal
cost
per
test
perform
consequ
platform
migrat
away
point
concern
favor
clinic
molecular
diagnost
laboratori
ii
smaller
sampl
volum
biochip
format
allow
smaller
sampl
volum
use
relev
sampl
avail
small
quantiti
tumor
biopsi
iii
integr
sampl
prepar
sampl
prepar
andor
workup
major
sourc
error
cost
mani
molecular
diagnost
abil
integr
unit
oper
cell
sort
lysi
protein
separ
pcr
onto
biochip
platform
major
advantag
although
save
time
limit
need
oper
involv
allow
diagnost
test
migrat
closer
site
interest
near
patient
physician
offic
bedsid
addit
major
challeng
includ
size
market
access
via
distribut
channel
repay
issu
last
like
import
forestal
could
potenti
largest
impact
way
health
care
provid
impact
diagnost
biochip
molecular
diagnost
must
await
result
research
target
product
develop
sever
compani
includ
millennium
predict
medicin
abbott
diagnost
bayer
abtech
scientif
activ
pursu
diagnost
product
product
develop
valid
clinic
tri
approv
fda
must
sold
tradit
conserv
medic
commun
commun
slow
adopt
new
diagnost
paradigm
due
part
mani
overhyp
claim
approach
past
genomicsderiv
molecular
diagnost
like
signific
impact
market
end
current
decad
burgeon
issu
uniqu
biochip
technolog
plural
technolog
approach
research
develop
commerci
market
forc
capit
speed
market
product
posit
rather
polici
requir
drive
endus
choic
among
sever
dozen
compet
biochip
technolog
avail
requir
sophist
softwar
program
power
comput
capabl
design
chip
function
well
captur
process
analysi
massiv
amount
data
gener
exampl
absenc
standard
format
compar
transfer
microarray
data
produc
propos
creat
standard
languag
facilit
share
data
among
scientist
open
structur
databas
gene
x
may
emerg
capabl
accept
affymetrix
genechip
data
cdna
data
spot
oligonucleotid
microarray
data
success
integr
clinic
databas
forerunn
dedic
system
use
clinic
diagnost
second
major
issu
diagnost
biochip
need
defin
appropri
complement
gene
larg
number
allel
variou
form
gene
appropri
decisionmak
requir
given
clinic
context
creat
pressur
two
oppos
side
need
licens
access
suffici
larg
number
gene
achiev
diagnost
purpos
compet
need
limit
total
number
gene
make
diagnost
commerci
viabl
elimin
downward
pressur
patent
licens
strategi
may
evolv
facilit
exchang
right
compet
entiti
right
legion
gene
util
biochip
platform
equit
streamlin
mechan
licens
gene
allel
would
help
promot
continu
research
develop
commerci
one
propos
advanc
creat
compulsori
licens
scheme
dna
sequenc
use
gene
chip
model
statutori
licens
arrang
music
copyright
act
third
confound
issu
pit
genet
screen
use
genom
microarray
target
diagnost
biochip
like
econom
multipl
genet
test
make
prefer
screen
mani
diseas
suscept
use
genom
microarray
although
screen
may
benefit
rais
sever
question
adequ
intervent
therapi
reveal
screen
ii
privaci
right
patient
adequ
protect
iii
genet
counselor
suitabl
prepar
guid
interpret
myriad
riskbas
assess
associ
broad
genom
screen
iv
inform
consent
obtain
given
broad
rang
possibl
outcom
screen
question
may
adequ
address
establish
procedur
institut
review
board
irb
tier
inform
consent
recontact
followup
protocol
anonym
keycod
patient
data
potenti
economi
scale
screen
patient
must
balanc
patient
right
privaci
protect
potenti
full
genom
scan
reveal
current
known
individu
also
enter
databas
may
known
futur
individu
also
progeni
sibl
lineag
must
dampen
enthusiasm
genom
screen
solut
develop
specif
gene
chip
diagnost
prognost
biochip
target
specif
diseas
state
genet
condit
evid
current
genom
gene
chip
replac
dedic
oncochip
arthriti
chip
assur
individu
protect
meet
rigor
requir
irb
approv
fourth
issu
relat
diagnost
biochip
test
aris
accumul
detail
health
inform
databank
databank
power
valuabl
tool
help
understand
counteract
diseas
process
rais
question
equiti
access
pariti
use
structur
inquiri
societ
benefit
cours
issu
must
balanc
intellectu
properti
right
invest
develop
databas
diagnost
biochip
emerg
highli
quantit
clinic
focus
molecular
diagnost
tool
modern
diagnost
laboratori
howev
road
destin
fill
regulatori
requir
societ
concern
technolog
practition
commun
must
cogniz
respons
furthermor
technolog
current
format
laborintens
quit
expens
need
altern
format
focu
specif
diagnost
prognost
applic
within
target
diseas
state
better
method
manufactur
detect
develop
includ
direct
detect
hybrid
electr
current
base
fact
singlestrand
dna
conduct
electron
differ
rate
doublestrand
dna
near
futur
nucleic
acid
nanotechnolog
may
prove
use
dna
diagnost
research
led
advanc
nucleic
acid
nanostructur
devic
semisynthet
dnaprotein
conjug
effici
assembl
individu
oligonucleotidefunction
nanoparticl
twoand
threedimension
network
assembl
alreadi
proven
use
diagnost
purpos
construct
nanometers
dnabas
nanowir
achiev
latter
incorpor
dnabas
twodimension
network
function
scaffold
protein
array
short
time
similar
dna
array
develop
